Related Experiment Video
Updated: Apr 11, 2026

14:14
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.5K
Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE
Lars Timmermann1, Roshini Jain2, Lilly Chen2
1Department of Neurology, University Hospital Cologne, Cologne, Germany.
The Lancet. Neurology
|June 2, 2015
Summary
A new multiple-source deep brain stimulation (DBS) device effectively reduced motor symptoms in Parkinson's disease patients. The system demonstrated an acceptable safety profile in a multicenter study.
Area of Science:
- Neurology
- Neurosurgery
- Biomedical Engineering
Background:
- High-frequency deep brain stimulation (DBS) using a single electrical source is established for Parkinson's disease (PD) motor symptom relief.
- A novel hypothesis proposed that a multiple-source, constant-current DBS device could enhance motor improvement in PD patients.
Purpose of the Study:
- To evaluate the efficacy and safety of a novel implantable multiple-source, constant-current DBS system for Parkinson's disease motor symptom management.
- To assess the impact of this advanced DBS technology on the Unified Parkinson's Disease Rating Scale Part III (UPDRS III) scores.
Main Methods:
- A prospective, multicenter, open-label study (VANTAGE) involving 53 patients with idiopathic Parkinson's disease across six European centers.
- Participants received bilateral subthalamic nucleus implantation of an eight-contact, rechargeable DBS system.
- Primary endpoint: mean change in UPDRS III scores from baseline to 26 weeks post-implantation, assessed in a medication-off state.
Main Results:
- Significant motor symptom improvement observed, with a mean reduction of 23.8 points in UPDRS III scores at 26 weeks (p<0.0001).
- Forty patients completed the primary endpoint analysis, demonstrating sustained efficacy.
- The system exhibited an acceptable safety profile, with most adverse events being mild and transient; three serious adverse events were device/procedure-related and resolved fully.
Conclusions:
- The multiple-source, constant-current DBS system effectively suppressed motor symptoms in Parkinson's disease patients.
- The device demonstrated an acceptable safety profile, warranting further investigation into its long-term benefits and side-effect profile.

